We are live on
!
Find out more
TM
Taproot Management Portfolio holdings
AUM
$530M
This Fund
S&P 500
This Quarter
Est. Return
+0.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$530M
AUM Growth
-$87.6M
(-14%)
Cap. Flow
-$76.4M
Cap. Flow
% of AUM
-14.42%
Top 10 Holdings %
Top 10 Hldgs %
16.44%
Holding
243
New
96
Increased
35
Reduced
49
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVB
AvalonBay Communities
AVB
|
+$8.86M |
| 2 |
AbbVie
ABBV
|
+$8M |
| 3 |
Abbott
ABT
|
+$7.95M |
| 4 |
Coca-Cola
KO
|
+$7.75M |
| 5 |
Elevance Health
ELV
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$11.3M |
| 2 |
Sanofi
SNY
|
+$10.2M |
| 3 |
Medtronic
MDT
|
+$10.2M |
| 4 |
Factset
FDS
|
+$9.91M |
| 5 |
GE Vernova
GEV
|
+$9.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.6% |
| 2 | Industrials | 20.75% |
| 3 | Consumer Discretionary | 16.07% |
| 4 | Consumer Staples | 12.4% |
| 5 | Real Estate | 11.75% |
Similar funds
FGAM
BFIC
AIM
CTWM
PFG
RAA
OCM
JHCP
Taproot Management's Q1 2026 Portfolio in Review
As of Q1 2026, Taproot Management held 243 positions worth $530M, down 14% from $617M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Taproot Management withdrew a net $76.4M in Q1 2026, closing 63 positions and reducing 49 holdings. Its most notable exit was Boston Scientific, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Taproot Management opened a new position in AbbVie worth $7.85M.
- Taproot Management's largest Q1 2026 buy was AbbVie: 36,080 shares worth $7.85M.
- Taproot Management added most to AvalonBay Communities in Q1 2026, an estimated $8.86M increase.
- Taproot Management's biggest Q1 2026 reduction was Jabil, cutting an estimated $9.26M.
- Taproot Management fully exited Boston Scientific in Q1 2026, selling an estimated $11.3M.
- Taproot Management's ten largest holdings make up 16% of its $530M portfolio in Q1 2026.
- Taproot Management opened 96 new positions and closed 63 in Q1 2026.
- Taproot Management's portfolio value fell 14% quarter-over-quarter to $530M.
Based on Taproot Management's 13F filing for Q1 2026, filed 13 May 2026.